1038408-36-4 Usage
Description
6-bromo-1-isopropyl-2-methyl-1H-benzo[d]imidazole is an organic compound characterized by its unique molecular structure, which features a benzimidazole core with a bromine atom at the 6th position, an isopropyl group at the 1st position, and a methyl group at the 2nd position. 6-bromo-1-isopropyl-2-methyl-1H-benzo[d]imidazole is known for its potential applications in various fields due to its specific chemical properties.
Uses
Used in Pharmaceutical Industry:
6-bromo-1-isopropyl-2-methyl-1H-benzo[d]imidazole is used as an intermediate compound for the synthesis of Amino Pyrimidine compounds. These Amino Pyrimidine compounds are known for their ability to inhibit protein Tyrosine kinase activity, which plays a crucial role in various cellular processes, including cell growth, differentiation, and apoptosis. By inhibiting this activity, these compounds can potentially be used in the development of therapeutic agents for the treatment of diseases associated with abnormal cell proliferation, such as cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 1038408-36-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,8,4,0 and 8 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1038408-36:
(9*1)+(8*0)+(7*3)+(6*8)+(5*4)+(4*0)+(3*8)+(2*3)+(1*6)=134
134 % 10 = 4
So 1038408-36-4 is a valid CAS Registry Number.
1038408-36-4Relevant articles and documents
AMINO PYRIMIDINE COMPOUND FOR INHIBITING PROTEIN TYROSINE KINASE ACTIVITY
-
, (2019/06/07)
An amino pyrimidine compound for inhibiting protein tyrosine kinase activity, a pharmaceutical composition thereof, preparation therefor, and an application thereof. Specifically, an amino pyrimidine compound represented by formula (I), R1, R2, L, Y, R6, W, A, m, and n being defined in the specification, and a pharmaceutically acceptable salt, a stereoisomer, a solvent compound, a hydrate, a polymorphism, a prodrug, or an isotope variant thereof. The compound can be used for treating and/or preventing protein tyrosine kinase-related diseases such as cell proliferative diseases, cancers, and immune diseases.